Objective: Our goal was to define the innate immune response in a model of genetic hypertension and the influences of cholinergic stimulation and Ang II.
I nflammation, as measured by proinflammatory cytokines (interleukin [IL]-17, intercellular adhesion molecule-1, IL-6, tumor necrosis factor α [TNFα]), is implicated in the development and maintenance of hypertension in patients and experimental models of angiotensin-dependent hypertension. 1, 2 T lymphocytes, members of the adaptive immune system, have been directly implicated in the development of hypertension. 3, 4 The spontaneously hypertensive rat (SHR) is a well-accepted genetic model of essential hypertension and is known to manifest dysregulation of the immune system. [5] [6] [7] Although dysregulated immune responses are implicated in the development of hypertension, the mechanisms remain unknown.
Autonomic dysfunction, characterized by increased sympathetic and decreased parasympathetic activity, is associated with increased mortality in cardiovascular disease 8 and correlates with the development of hypertension. 9 Notably, the SHR has also been shown to be a good model for autonomic dysfunction,
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with enhanced chemoreceptor and decreased baroreceptor activity. 8, 10, 11 Studies that show anti-inflammatory and proinflammatory effects of cholinergic and adrenergic stimulation, respectively, [12] [13] [14] potentially help explain the mechanism by which autonomic dysfunction leads to hypertension and contributes to cardiovascular mortality. Tracey et al have shown that nicotine suppresses innate immune cytokine responses in macrophages in a murine model of sepsis. 15, 16 Furthermore, central delivery of angiotensin II (Ang II) activates peripheral sympathetic nerve activity and enhances splenic cytokine gene expression, suggesting that Ang II may contribute to the development of hypertension by stimulating a neurally mediated proinflammatory immune response in the spleen, 17 in addition to its direct renal effects. The SHR has been used as a genetic model for essential hypertension because it develops hypertension as it ages. Hypertension in SHRs begins at about 6 weeks of age, and at 4 to 5 weeks of age the SHRs are in the prehypertensive period. 18, 19 Given the autonomic dysfunction and immunologic abnormalities present in the SHR, [5] [6] [7] [8] 10 it serves as an ideal model for the investigation of neurohormonal regulation of innate immune responses. Although the adaptive immune system has been implicated in hypertension, 2,3 the role of the innate immune system remains undefined. We hypothesized that there is a dysregulation of innate immune responses before the development of hypertension in SHRs. In the present work, we use Toll-like receptor (TLR) ligands to activate the innate immune response. These TLRs detect pathogen-associated molecular patterns and damage-associated molecular patterns and induce cytokine production and release that trigger the activation of the acquired/adaptive immune system. 20 The modulation of the cytokine response to TLR activation by nicotine and Ang II was contrasted in young Wistar Kyoto (WKY) normotensive rats and the young prehypertensive SHRs. In the WKY rats, nicotine suppressed the cytokine response, but in SHR rats, nicotine, as well as Ang II, significantly enhanced the cytokine response. We propose that this abnormal proinflammatory modulation of the innate immune system which precedes the onset of hypertension contributes significantly to its development in the SHR.
Methods

Please see the Online Data Supplement for detailed Materials and
Methods.
Animals
Male WKY rats and SHRs (Charles River Laboratories) were used at 4 to 5 weeks of age.
TLR Activation
Several Toll receptors recognize specific extra-or intracellular ligands and induce nuclear factor-κB activation in immune cells and the release of inflammatory cytokines. Responses to the TLR ligand activation were measured in supernatants of cultured splenocytes in vitro, as well as in blood in vivo.
Splenocyte Cultures
Splenocytes from 4-to 5-week-old animals were stimulated in vitro with known TLR ligands in the presence or absence of preexposure to nicotine or Ang II. Culture supernatants were collected, and IL-6, TNFα, and IL-10 were measured by ELISA.
In Vivo Studies
Subcutaneous osmotic minipumps were implanted and infused either saline or nicotine over 24 hours (15 mg/kg). At 20 hours, animals received an intraperitoneal injection of either saline or the TLR7/8 ligand (Clo97). Serum was collected from each animal, and IL-6, IL-1β, TNFα, IL-10, and IL-17 were measured at 24 hours.
Flow Cytometry
Splenocytes were stained with fluorochrome-conjugated antibodies to CD3, CD4, CD8, CD45R, CD11 bc , CD161a, and major histocompatibility complex-II and analyzed by flow cytometry.
Results
Cytokine Release From Splenocytes in Response to TLR Activation Is Pronounced With TLR7/8 and -9 and Equivalent in SHRs and WKY Rats
We first asked whether the native innate immune response of the SHRs differed from the normotensive WKY rats. Splenocytes were stimulated with 3 graded doses of the ligands for TLR2, TLR3, TLR4, TLR5, TLR7/8, and TLR9, as listed in the legend of Figure 1 . Similar levels of TNFα ( Figure 1A ), IL-10 ( Figure 1B) , and IL-6 ( Figure 1C ) were induced in WKY and SHR splenocytes in response to TLR activation. The most robust responses were seen with TLR7/8 and TLR9 activation. Nicotine and Ang II alone did not induce cytokine secretion from either WKY or SHR splenocytes ( Figure 1 ).
Modulation of TLR-Induced IL-6 Secretion by Nicotine and Ang II Is Markedly Proinflammatory in SHRs
Although nicotine and Ang II did not directly induce the secretion of cytokines, exposure of splenocytes to nicotine (10 μmol/L) and Ang II (1 μmol/L) for 2 hours before the addition of TLR ligands resulted in significant modulation of TLR-induced IL-6 secretion. In WKY splenocytes, nicotine preexposure suppressed TLR9-mediated IL-6 secretion ( Figure 2A ). In contrast, nicotine exposure of SHR splenocytes resulted in a dramatic increase in the release of IL-6 ( Figure 2B ) in response to TLR7/8 and TLR9. Ang II exposure of WKY splenocytes did not alter TLR-mediated IL-6 release ( Figure 2C ) but led to a significant increase in TLR-mediated IL-6 release in SHR splenocytes, similar to the effect of nicotine ( Figure 2D ).
Based on the robust responses to activation of TLR7/8 and TLR9, we focused on these receptors in subsequent experiments ( Figure 3 ). We continued to see uniformly suppressive effects of nicotine on TLR responses in WKY splenocytes ( Figure 3A ) and uniformly enhanced effects of both nicotine and Ang II in SHR splenocytes ( Figure 3B and 3D). Ang II exposure did not appreciably alter the TLR responses in WKY splenocytes ( Figure 3C ).
In Vivo Effect of Nicotine and Ang II on TLR7/8-Mediated Cytokine Production: Inhibitory in WKY Rats and Proinflammatory in SHRs
We asked whether the contrasting nicotine effects seen in vitro would be reproduced in vivo. We found that subcutaneous infusion of nicotine alone or Ang II alone demonstrated a trend Ach  acetylcholine  Ang II  angiotensin II  AT1  angiotensin type 1  IL-1β interleukin-1 β IL-6 interleukin-6 PPARγ peroxisome proliferator-activated receptor gamma s.c. subcutaneous SHR spontaneously hypertensive rats TLR Toll-like receptor TNFα tumor necrosis factor-α WKY Wistar-Kyoto rats α7 nAChR α-7 nicotinic acetylcholine receptor October 12, 2012 of increased serum levels of IL-6 and IL-1β in both WKY rats ( Figure 3E and 3G) and SHRs ( Figure 3F and 3H). We also found that the serum levels of both IL-6 and IL-1β in response to TLR7/8 activation with Clo97 (intraperitoneally) were markedly suppressed by the subcutaneous infusion of nicotine in WKY rats ( Figure 3E ) and conversely significantly enhanced in SHRs ( Figure 3F ). Ang II did not alter the TLR responses of IL-6 and IL-1β in WKY rats ( Figure 3G ), but in SHRs the IL-1β response was significantly enhanced and the increase in IL-6 was not significant ( Figure 3H ). Thus, the anti-inflammatory Of the 6 TLR ligands tested, nicotine and Ang II most significantly altered the responses to TLR7 and TLR9. Both nicotine and Ang II dramatically enhanced the IL-6 responses to TLR7 and TLR9 ligands in SHR splenocytes whereas nicotine suppressed the response in WKY splenocytes and Ang II did not alter it significantly. Responses of tumor necrosis factor α (TNFα) and IL-10 were not altered by nicotine or Ang II (data not shown). modulation of TLR responses by nicotine seen in the WKY splenocytes and the proinflammatory enhancements by nicotine and Ang II seen in SHR splenocytes were reproduced in vivo.
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Activated Macrophages in the SHR Are Increased by Nicotine
Based on the clearly opposite effects of nicotine on IL-6 secretion in WKY rats and SHRs, both in vitro and in vivo, we asked whether there was a difference in the immune cell subpopulations in SHRs versus WKY rats and used flow cytometry to answer this question.
Although there was no difference in the distribution of CD3+/ CD8+, CD3+CD4+, CD11bc+, or CD45R+ immune cells, we found a discordance in the composition of CD3 − /CD8 bright and CD3 − /CD8 dim cell populations, with an increase in the latter in SHR compared with WKY splenocytes (Figure 4 ). Further analysis of the CD3 − /CD8 dim cells was made by assessing CD161a, a marker of activated macrophages. We found a CD161a population that was more dominant in SHR (4.6%) compared with WKY splenocytes (1.1%) and expanded in response to nicotine to 6.4%, whereas the WKY population remained at 1.1%. Another marker of activated macrophages (CD3 − /CD8 − / CD161a+) was also increased in SHR splenocytes and expanded further from 3.7% to 6.0% in response to nicotine (Figure 4 ). This population also remained low in WKY splenocytes (1.5%), despite the presence of nicotine ( Figure 4 ). Hence, there seems to be a population of activated macrophages (CD161a+) present in the SHR splenocytes, but not in the WKY splenocytes, before the development of hypertension, which may account for the proinflammatory enhancement of the TLR-induced increase in IL-6 and IL-1β levels.
Effect of Nicotine on Myeloid Dendritic Cells in WKY Rats
Preliminary findings reported in the Online Figures II to IV indicate suppression of a major histocompatibility complex-II+ CD11bc+ myeloid dendritic cell population by nicotine exclusively in WKY splenocytes but not in SHR splenocytes, which may account for the anti-inflammatory effect of nicotine.
Discussion
The major finding of this study is that SHRs exhibit a proinflammatory innate immune response (measured by IL-6 and IL-1β) before the development of hypertension, which suggests its contribution to the development of hypertension. It is most pronounced with activation of TLR7/8 and TLR9. Nicotine (E and F) and Ang II (G and H) when given with intraperitoneal saline increased IL-6 and IL-1β in WKY rats and to a lesser extent in SHRs. In WKY rats, nicotine (subcutaneous) significantly suppressed IL-6 and IL-1β responses to intraperitoneal Clo97 (E). In contrast, in SHRs, nicotine significantly enhanced both IL-6 and IL-1 β responses (F). Ang II had no effect on the responses in WKY rats (G), yet it significantly enhanced the IL-1β response in SHRs (H). *Significant differences between responses to Nic/TLR or Ang/TLR vs saline/TLR in both WKY rats and SHRs (P<0.01). The anti-inflammatory effects of nicotine in WKY splenocytes and proinflammatory effects of nicotine and Ang II in SHR splenocytes were thus confirmed in vivo. October 12, 2012
Nicotine, a ligand for cholinergic receptors, is anti-inflammatory in the normotensive control WKY rats but is paradoxically proinflammatory in SHRs. An accentuated proinflammatory response to Ang II is also seen in SHRs but not in WKY rats. Changes in innate immune cell populations with exposure to nicotine correlate with the anti-inflammatory effects of nicotine in WKY rats and proinflammatory effects in young SHRs.
In the Discussion section, we will address the following: (1) the contribution of the innate immune system in human hypertension and SHRs; (2) the functional relevance of immune responses to nicotine and angiotensin to the survival advantage of parasympathetic activation and angiotensin-converting enzyme inhibition in cardiovascular disease; (3) the prominent effect of ligands of TLR7/8 and TLR9 relative to other TLRs (which is presented in the Online Data Supplement); and (4) the changes in populations of CD161a+ activated macrophages and possibly myeloid dendritic cells, which may account for the dramatically opposite effects of nicotine in WKY rats and SHRs.
Inflammation and Innate Immunity in Human Hypertension and SHRs
Circulating inflammatory cytokines have been detected in the sera of hypertensive patients 1 ; furthermore, amounts of IL-6 and IL-1β in whole blood of patients with essential hypertension were exaggerated in response to TLR4 activation with lipopolysaccharide, consistent with the activation of monocytes. 21 Similarly, the genetically hypertensive adult SHRs have elevated blood levels of innate immune cytokines (IL-6 and IL-1β) compared with WKY rats. 22 Furthermore, the systemic inhibition of nuclear factor-κB in SHRs decreases renal inflammation and results in significant reductions of systolic blood pressure.
Our results focused on the prehypertensive (normotensive) young SHRs. Previous studies 18 and preliminary results from our laboratory 19 have shown that SHRs are normotensive at 4 to 5 weeks of age. In the present study, we show that activation of isolated splenocytes with several TLR ligands induced increases in IL-6, TNFα, and IL-10, which are comparable in the prehypertensive SHR with those of normotensive WKY rats. Also, in vivo TLR activation caused increases in IL-6 and IL-1β blood levels in both WKY rats and SHRs. More importantly, however, an enhanced proinflammatory response to TLR activation similar to that seen in patients with essential hypertension was unmasked in our prehypertensive SHRs by nicotine and Ang II in vitro and in vivo.
In contrast, in the WKY rats, nicotine that had been reported to suppress inflammatory responses by activating α7 nicotinic acetylcholine receptors (nAChRs) 16 suppressed the increase in IL-6 in vitro and the increases in IL-6 and IL-1β in vivo. Ang II had no effect on the cytokine response to TLR activation in WKY rats.
The results indicate that there is an abnormal proinflammatory state of the innate immune system in the prehypertensive SHR, which is provoked by nicotine and Ang II, when TLR 7/8 and TLR9 are activated, and may thereby contribute to the development of hypertension in this model. We also note an anti-inflammatory effect of nicotine in the WKY rats, which is probably mediated by α7 nAChRs.
Functional Relevance of Inflammatory Responses to Nicotine and Ang II to the Survival Advantage of Parasympathetic Stimulation and Angiotensin-Converting Enzyme Inhibition in Cardiovascular Disease
Autonomic dysfunction with increased sympathetic nerve activity and decreased parasympathetic activity has been correlated with increased cardiovascular mortality 23 and the development of hypertension. 24, 25 The attempt to restore autonomic balance with direct carotid sinus and vagal stimulation has shown promise in the treatment of hypertension and heart failure. 26 Classically, autonomic dysfunction has referred to the imbalance of neural activity between the parasympathetic and the sympathetic nervous systems. Recently, the neurotransmitters of the autonomic nervous system have been shown to not only be produced by, but also exert effects on, non-neuronal cells, expanding the conceptual importance of autonomic dysfunction. 27 There is direct sympathetic innervation of immunologic organs. 28 Activation of adrenergic receptors has been shown to induce a proinflammatory immune response. 29, 30 In contrast, it has been shown that the vagus nerve stimulation exerts an antiinflammatory effect in the gut in a murine model for sepsis. 15 Vagal nerve stimulation also exerts an immunomodulatory effect on a subset of splenic T lymphocytes, which produces and secretes acetylcholine (Ach) in response to adrenergic input from the splenic nerve. 28, 31, 32 The results of the present study suggest novel mechanisms by which autonomic regulation of immune responses may increase cardiovascular mortality or be protective and beneficial.
Cholinergic Anti-Inflammatory Immunomodulation: Role of α7 nAChRs
Our data show that there is an anti-inflammatory modulation in the normotensive WKY rats by nicotine, which in preliminary results is blocked by α-bungarotoxin, a blocker of α7 nAChR (Online Figure I) . The paradoxically enhanced proinflammatory modulation of the TLR response by nicotine in SHRs was not altered by α-bungarotoxin and cannot be attributed to decreased expression of α7 nAChR in SHRs. It has been shown that the expression of α7 nAChRs is similar in prehypertensive SHRs and age-matched WKY rats. 33 Interestingly, there are reports of decreased expression of α7 nAChRs in the central nervous system of the stroke-prone SHRs 34 and in older (≥20-week) hypertensive SHRs. 33 Furthermore, α7 nAChR agonists decrease the inflammatory end-organ damage in the hypertensive SHR, 33 and recent studies in α7 nAChR knockout mice show an enhanced inflammatory end-organ response in the 2 kidney/1 clip model of hypertension. 33 There is also evidence that T cells in the WKY rats and SHRs produce ACh and express ACh receptors 35 and that circulating, thymic, and splenic levels of ACh in the very young SHRs are elevated but decreased with aging up to 20 weeks compared with the WKY age-matched controls. 35 
Nicotinic Proinflammatory Immunomodulation in SHRs
Although α7 nAchRs are potent suppressors of the inflammatory response and can protect the end organs from hypertensive damage, many other nAChR subunits 36 and G protein-coupled receptors may be involved in proinflammatory responses. In a recent study, 37 it was reported that nicotine and Ang II activate respective G protein-coupled receptors on vascular muscle cells and increase intracellular reactive oxygen species and cytokines (IL-6, 1FN-γ) that promote activation of AMP-kinase α2 and its nuclear translocation with the induction of transcription factors, such as matrix metalloproteinase 2.
Hence, there are clear indications of a cholinergic influence on the immune system and on end organs through α7 nAChRs, ACh production, or activation of other nicotinic receptors. The interaction may be protective or paradoxically inflammatory. Our results identify a significant proinflammatory innate immune system abnormality that precedes the development of hypertension in SHRs. Further characterization of the cellular and molecular determinants of that interaction needs to be examined.
Proinflammatory Immunomodulation by Ang II in SHRs
Ang II is clearly involved in the pathogenesis of hypertension through neural, renal, and vascular mechanisms. In addition, Ang II activates nuclear factor-κB, causing the expression of proinflammatory cytokines in vitro and in vivo. 38 Inhibition of angiotensin-converting enzyme reduces cardiac inflammatory markers in SHRs by inactivating nuclear factor-κB. 22 Angiotensin type 1 receptor blockade reduces lipoploysaccharide-induced innate immune responses in rat spleen, 38 reverses renal inflammation, 39 and also reduces vascular and circulating inflammatory mediators in SHRs. 40 Although we found that both nicotine and Ang II had no direct effect on cytokine release from splenocytes in culture, their systemic infusions did increase serum levels of IL-6 and IL-1β in both WKY rats and SHRs. This proinflammatory response may be secondary to an increase in sympathetic nerve activity through a central action of Ang II or ganglionic effect of nicotine.
Our results shed light on a novel mechanism by which Ang II may be proinflammatory in a model of genetic hypertension. It induces a marked enhancement of secretion of IL-6 and IL-1β from splenocytes of prehypertensive SHRs in response to TLR activation. This proinflammatory response, similar to that elicited by nicotine, is immunomodulatory because Ang II alone did not induce secretion of detectable levels of cytokines. Interestingly, our preliminary results demonstrate that the angiotensin type 1 receptor blocker losartan not only prevents the proinflammatory effect of Ang II in SHRs but also reduces IL-6 release to levels below those seen in the absence of Ang II (Online Figure I ). An inhibitory effect of losartan on inflammatory signaling mediated by peroxisome proliferator-activated receptor γ has been reported. 41 
Prominent Contribution of TLR in Activating Innate Immunity in Hypertension
A description of TLRs and their linkage to hypertension and the innate immune system is discussed in the Online Data Supplement.
Changes in Populations of Innate Immune Cells With Nicotine Differ in WKY Rats and SHRs
Dendritic cells and macrophages are members of the innate immune system and serve as antigen-presenting cells, thus activating T lymphocytes and playing a role in their differentiation. Natural killer cells are also important members of the innate immune system. We show that there is a more prominent CD3 − / CD161a+ cell population in the SHR splenocytes that appeared to be further induced by nicotine preexposure (Figure 4 ). We postulate that the expansion of this cell population may be mediated by IL-6, which is known to affect the differentiation of monocytes to macrophages. 42 CD161a is a marker for natural killer cells, dendritic cells, and activated macrophages. 43, 44 Thus, it appears that enhanced activation of macrophages, which is not seen in WKY rats, would explain the proinflammatory effect of nicotine. We are currently exploring the distribution of the various innate immune cells, including dendritic cell subsets, natural killer cells, and, possibly, natural killer T cells. Preliminary results included in the Online Data Supplement (Online Figures  II-IV) suggest that the anti-inflammatory effect of nicotine in WKY rats represents a suppression of a larger population of myeloid dendritic cells not seen in SHRs.
Conclusions
The results of the current study support the novel concept of neurohormonal modulation of the innate immune system as a pathogenic mechanism in genetic hypertension before the onset of hypertension. 45 Furthermore, the results begin to identify cellular targets of interest that may mediate these effects. We show evidence that the innate immune system is abnormally primed and sensitized in SHRs to be highly proinflammatory in response to putative cholinergic and angiotensinergic stimuli.
